Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ensysce Biosciences Inc (NQ: ENSC ) 0.6694 +0.0194 (+2.98%) Streaming Delayed Price Updated: 10:40 AM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ensysce Biosciences Inc < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Dow Jumps Over 100 Points; Nvidia Earnings Top Views August 29, 2024 Via Benzinga Topics Stocks Exposures US Equities Ensysce Biosciences, Inc. Announces $5 Million Concurrent Registered Direct Offering and Exercise of Warrants August 29, 2024 Via ACCESSWIRE Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket August 28, 2024 Via Benzinga Ensysce Biosciences Announces IRB Approval for Key MPAR Study August 27, 2024 Via ACCESSWIRE Ensysce Biosciences Provides Key Themes Following IASP 2024 Symposium August 06, 2024 Via ACCESSWIRE Ensysce Biosciences Provides Mid-Year 2024 Update July 23, 2024 Via ACCESSWIRE S&P 500 Edges Higher; American Woodmark Shares Slide August 27, 2024 Via Benzinga Topics Stocks Exposures US Equities Crude Oil Dips; Addex Therapeutics Shares Spike Higher August 27, 2024 Via Benzinga Exposures Fossil Fuels US Stocks Mixed; ScanSource Reports Weak Q4 Results August 27, 2024 Via Benzinga ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q2 2024 August 14, 2024 ENSC stock results show that Ensysce Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace Ensysce Biosciences Reports Second Quarter 2024 Financial Results August 14, 2024 Via ACCESSWIRE Ensysce Biosciences Hosts IASP 2024 Symposium and Presents Clinical Dataset July 09, 2024 Via ACCESSWIRE Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting June 27, 2024 Via ACCESSWIRE Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate June 25, 2024 Via ACCESSWIRE Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program June 06, 2024 Via ACCESSWIRE ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q1 2024 June 24, 2024 ENSC stock results show that Ensysce Biosciences beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket June 21, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session June 20, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session June 18, 2024 Via Benzinga Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting June 03, 2024 Via ACCESSWIRE Ensysce Biosciences Reports First Quarter 2024 Financial Results May 13, 2024 Via ACCESSWIRE Ensysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge Magazine April 25, 2024 Via ACCESSWIRE Ensysce Biosciences' Presentation from the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference Published April 19, 2024 Via ACCESSWIRE Ensysce Biosciences Regains Compliance with Nasdaq May 28, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 23, 2024 Via Benzinga Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform May 20, 2024 Via ACCESSWIRE Ensysce Biosciences to Participate in the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference April 09, 2024 Via ACCESSWIRE FSR Stock: The $150 Million Reason Fisker Shares Are Moving Today March 18, 2024 Fisker stock is on the move Monday as FSR investors learn about the EV company securing an additional $150 million in funding. Via InvestorPlace Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results March 15, 2024 Via ACCESSWIRE ENSC Stock Earnings: Ensysce Biosciences Misses EPS, Beats Revenue for Q4 2023 March 18, 2024 ENSC stock results show that Ensysce Biosciences missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
